drugset / Trial / NCT03673163

Lidocaine Infusion for Pain After Herniotomy

NCT03673163 ↗

Unknown 180 enrolled Guangzhou First People's Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study seeks to investigate lidocaine infusion to reduce occurrence of chronic postoperative pain at 3-month after inguinal herniotomy

Timeline

Start
2018-11-06
Primary completion
2019-06-30
Completion
2019-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 % Intravenous

Indications